| Product Code: ETC070062 | Publication Date: Jun 2021 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The South Korea Biobanking Market was estimated at USD 277 Million in 2025 and is projected to reach USD 369 Million by 2032, growing at a CAGR of 4.2% from 2026 to 2032. This growth trajectory is fueled by a combination of increasing investments in research and development, heightened awareness surrounding personalized medicine, and a significant rise in the demand for high-quality biological samples across various research applications. As the country embraces advanced biobanking technologies, it solidifies its position as a leader in the biomedical research landscape.
The South Korean biobanking market exhibits stable growth, with projected yearly increases of 4.9% in 2021, followed by a slight dip to 4.8% in both 2022 and 2023. However, a rebound is anticipated with a growth rate of 5.1% in 2024. Factors driving this uptick include rising investments in healthcare infrastructure and enhanced consumer demand for personalized medicine. As the industry adapts to advancements in technology and digitalization, it maintains a robust outlook, sustaining growth rates of around 5% through 2029. Despite some fluctuations, such as the expected 4.6% growth in 2031, the market remains buoyed by effective policy frameworks and ongoing innovation, particularly in genomics and biopharmaceuticals.
This graph highlights how the South Korea Biobanking Market has steadily grown over the past five years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | 4.9% | Expansion of manufacturing activities |
| 2022 | 4.8% | Growing urbanization and commercial development |
| 2023 | 4.8% | Expansion of transportation and logistics networks |
| 2024 | 5.1% | Expansion of manufacturing activities |
| 2025 | 4.9% | Increasing industrial infrastructure investments |
| 2026 | 4.8% | Increasing smart city development projects |
| 2027 | 5.0% | Growing urbanization and commercial development |
| 2028 | 5.0% | Increasing industrial infrastructure investments |
| 2029 | 5.0% | Expansion of transportation and logistics networks |
| 2030 | 4.7% | Expansion of commercial construction activities |
| 2031 | 4.6% | Rising electricity demand across industries |
| 2032 | 5.2% | Expansion of commercial construction activities |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
In recent years, the South Korea biobanking market has experienced robust momentum, supported by government initiatives and public-private collaborations. However, as the market evolves, it is on the brink of a transformative phase driven by advancements in precision medicine and an expanding array of research applications. This evolution promises not only to enhance the quality of research but also to elevate the country’s standing in global healthcare innovation.
The push towards integrating diverse biological samples into biobanks is changing the game, allowing for more comprehensive research into critical areas such as oncology and infectious diseases. As awareness of the value of biobanking grows among research communities and the general public alike, the market is set to thrive in the coming years, underpinned by a strong foundation of academic and industrial collaboration.
Despite its potential, the South Korea biobanking market faces several restraints. Regulatory complexities regarding the collection, storage, and sharing of biological samples pose significant challenges for biobanks. Moreover, there is a pressing need for standardized procedures and robust data management practices to ensure reliability and integrity. The general public's limited understanding of biobanking's importance can also hamper donor participation, which is crucial for expanding sample collections. Addressing these challenges will be essential for unlocking the full potential of the market and facilitating ongoing advancements in healthcare and research.
A number of current and emerging trends are shaping the South Korea biobanking market. The adoption of advanced technologies, including automated sample storage systems and AI-driven data analysis, is transforming the operational landscape. Furthermore, there is an increasing emphasis on broadening biobank collections to encompass diverse population groups, which enriches research capabilities. Enhanced focus on regulations and quality standards is also evident, ensuring the integrity of stored biological materials. Such trends highlight a future where biobanks are not merely storage facilities but pivotal players in health research and innovation.
The South Korea biobanking market is ripe with opportunities for investment and growth. As demand for high-quality biological samples continues to rise, there is a growing need for state-of-the-art biobanking facilities equipped with advanced sample management systems and security protocols. Investors can also capitalize on the development of innovative technologies, such as blockchain for secure data sharing and machine learning for enhanced data processing. Collaborations with academic institutions and healthcare providers will further catalyze innovation and create pathways for novel therapeutic discoveries.
The South Korean government is actively promoting the biobanking sector through robust policies and funding programs. The National Biobank of Korea Act plays a central role in governing the ethical collection, storage, and distribution of biological samples, ensuring compliance with safety and quality standards. Moreover, the Ministry of Food and Drug Safety is dedicated to maintaining stringent oversight of biobank practices, fostering a secure and ethical environment for research. This commitment to biobanking enhances the nation's infrastructure and encourages continued collaboration among various stakeholders.
Looking ahead to 2026-2032, the South Korea biobanking market is expected to witness substantial growth driven by rising chronic disease prevalence and an aging population. The market's trajectory is bolstered by ongoing government initiatives aimed at promoting biobanking and precision medicine, alongside increasing healthcare investments. With advancements in medical research and technology, stakeholders can anticipate a thriving biobanking ecosystem, poised to make significant contributions to healthcare outcomes and innovative therapeutic solutions.
Recent developments in the South Korea biobanking market highlight an ongoing commitment to innovation and collaboration. Academic institutions are increasingly partnering with private sector entities to enhance research capabilities and expand biobank collections. Concurrently, there is a noticeable shift towards integrating advanced technologies in biobanking operations, aiming to streamline processes and improve data security. These evolving dynamics reflect a vibrant market actively seeking to leverage biobanking as a cornerstone of precision medicine and personalized healthcare.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Biobanking Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Biobanking Market Revenues & Volume, 2022 & 2032F |
3.3 South Korea Biobanking Market - Industry Life Cycle |
3.4 South Korea Biobanking Market - Porter's Five Forces |
3.5 South Korea Biobanking Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 South Korea Biobanking Market Revenues & Volume Share, By Applications, 2022 & 2032F |
3.7 South Korea Biobanking Market Revenues & Volume Share, By Sample Type, 2022 & 2032F |
4 South Korea Biobanking Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and genomic research |
4.2.2 Government initiatives promoting biobanking and research activities |
4.2.3 Growing prevalence of chronic diseases driving the need for large-scale sample storage and analysis |
4.3 Market Restraints |
4.3.1 Lack of awareness and understanding about the benefits of biobanking |
4.3.2 Limited funding for biobanking infrastructure and research projects |
4.3.3 Data privacy and ethical concerns related to the storage and use of biological samples |
5 South Korea Biobanking Market Trends |
6 South Korea Biobanking Market, By Types |
6.1 South Korea Biobanking Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 South Korea Biobanking Market Revenues & Volume, By Type, 2022-2032F |
6.1.3 South Korea Biobanking Market Revenues & Volume, By Equipment, 2022-2032F |
6.1.4 South Korea Biobanking Market Revenues & Volume, By Consumables, 2022-2032F |
6.1.5 South Korea Biobanking Market Revenues & Volume, By Services, 2022-2032F |
6.1.6 South Korea Biobanking Market Revenues & Volume, By Software, 2022-2032F |
6.2 South Korea Biobanking Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 South Korea Biobanking Market Revenues & Volume, By Regenerative Medicine, 2022-2032F |
6.2.3 South Korea Biobanking Market Revenues & Volume, By Life Science Research, 2022-2032F |
6.2.4 South Korea Biobanking Market Revenues & Volume, By Clinical Research, 2022-2032F |
6.3 South Korea Biobanking Market, By Sample Type |
6.3.1 Overview and Analysis |
6.3.2 South Korea Biobanking Market Revenues & Volume, By Blood Products, 2022-2032F |
6.3.3 South Korea Biobanking Market Revenues & Volume, By Human Tissues, 2022-2032F |
6.3.4 South Korea Biobanking Market Revenues & Volume, By Nucleic Acids, 2022-2032F |
6.3.5 South Korea Biobanking Market Revenues & Volume, By Cell Lines, 2022-2032F |
6.3.6 South Korea Biobanking Market Revenues & Volume, By Biological Fluids, 2022-2032F |
6.3.7 South Korea Biobanking Market Revenues & Volume, By Human Waste Products, 2022-2032F |
7 South Korea Biobanking Market Import-Export Trade Statistics |
7.1 South Korea Biobanking Market Export to Major Countries |
7.2 South Korea Biobanking Market Imports from Major Countries |
8 South Korea Biobanking Market Key Performance Indicators |
8.1 Number of collaborations between biobanks and research institutions |
8.2 Growth in the number of samples stored in biobanks |
8.3 Adoption rate of advanced technologies for sample processing and analysis |
9 South Korea Biobanking Market - Opportunity Assessment |
9.1 South Korea Biobanking Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 South Korea Biobanking Market Opportunity Assessment, By Applications, 2022 & 2032F |
9.3 South Korea Biobanking Market Opportunity Assessment, By Sample Type, 2022 & 2032F |
10 South Korea Biobanking Market - Competitive Landscape |
10.1 South Korea Biobanking Market Revenue Share, By Companies, 2025 |
10.2 South Korea Biobanking Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here